Free Trial
→ Critical AI announcement set to ignite AI 2.0 (From Timothy Sykes) (Ad) Free CTS Stock Alerts

CTS (CTS) Financials

CTS logo
$38.49 +0.09 (+0.22%)
Closing price 08/7/2025 03:59 PM Eastern
Extended Trading
$38.54 +0.05 (+0.12%)
As of 08/7/2025 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for CTS

Annual Income Statements for CTS

This table shows CTS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 27 6.95 34 14 47 36 35 -42 60 61 58
Consolidated Net Income / (Loss)		 27 6.95 34 14 47 36 35 -42 60 61 58
Net Income / (Loss) Continuing Operations		 27 6.95 34 14 47 36 35 -42 60 61 58
Total Pre-Tax Income 		39 12 57 40 58 50 45 -61 81 75 71
Total Operating Income		 42 18 63 38 61 54 45 76 93 75 73
Total Gross Profit		 130 127 140 140 165 158 139 185 211 191 189
Total Revenue		 404 382 397 423 470 469 424 513 587 550 516
Operating Revenue		 404 382 397 423 470 469 424 513 587 550 516
Total Cost of Revenue		 274 255 256 283 306 311 285 328 376 360 327
Operating Cost of Revenue		 274 255 256 283 306 311 285 328 376 360 327
Total Operating Expenses		 88 109 77 102 104 104 94 108 118 116 116
Selling, General & Admin Expense		 61 60 62 72 74 70 68 83 92 84 88
Research & Development Expense		 23 22 24 25 25 26 24 24 24 25 23
Restructuring Charge		 5.94 15 3.05 4.14 5.06 7.45 1.83 1.69 1.91 7.07 4.70
Total Other Income / (Expense), net		 -2.98 -5.85 -5.92 1.76 -2.94 -3.55 0.35 -137 -12 0.10 -1.56
Interest Expense		 2.33 2.63 3.70 3.34 2.09 2.65 3.27 2.11 2.19 3.33 4.24
Interest & Investment Income		 2.79 3.07 1.31 1.28 1.83 1.74 1.05 0.84 1.33 4.63 4.28
Other Income / (Expense), net		 -3.44 -6.30 -3.52 3.82 -2.68 -2.64 2.58 -136 -11 -1.19 -1.60
Income Tax Expense		 13 5.31 23 26 12 14 11 -19 21 15 13
Basic Earnings per Share		 $0.79 $0.21 $1.05 $0.44 $1.41 $1.11 $1.07 ($1.30) $1.86 $1.93 $1.91
Weighted Average Basic Shares Outstanding		 33.62M 32.96M 32.73M 32.89M 33.02M 32.70M 32.32M 32.33M 31.97M 31.36M 30.41M
Diluted Earnings per Share		 $0.78 $0.21 $1.03 $0.43 $1.39 $1.09 $1.06 ($1.30) $1.85 $1.92 $1.89
Weighted Average Diluted Shares Outstanding		 34.13M 33.48M 33.25M 33.42M 33.57M 33.11M 32.58M 32.33M 32.24M 31.58M 30.72M
Weighted Average Basic & Diluted Shares Outstanding		 33.60M 33.10M 32.70M 32.80M 33M 64.87M 32.35M 32.15M 31.67M 30.79M 30.04M
Cash Dividends to Common per Share		 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16 $0.16

Quarterly Income Statements for CTS

This table shows CTS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 15 18 13 14 15 11 15 19 14 13 19
Consolidated Net Income / (Loss)		 15 18 13 14 15 11 15 19 14 13 19
Net Income / (Loss) Continuing Operations		 15 18 13 14 15 11 15 19 14 13 19
Total Pre-Tax Income 		21 23 16 19 18 14 18 22 17 16 23
Total Operating Income		 22 22 18 18 16 15 18 21 19 16 23
Total Gross Profit		 51 52 51 46 42 45 46 50 48 47 52
Total Revenue		 142 146 145 135 125 126 130 132 127 126 135
Operating Revenue		 142 146 145 135 125 126 130 132 127 126 135
Total Cost of Revenue		 91 94 94 88 83 81 84 83 80 79 83
Operating Cost of Revenue		 91 94 94 88 83 81 84 83 80 79 83
Total Operating Expenses		 29 29 32 28 26 31 29 28 29 30 30
Selling, General & Admin Expense		 23 22 24 19 19 22 21 23 22 24 23
Research & Development Expense		 5.41 6.59 6.72 6.32 5.29 6.60 6.09 5.03 5.67 6.19 6.33
Restructuring Charge		 0.48 0.91 1.90 3.23 1.04 1.69 1.19 0.77 1.04 0.45 0.30
Total Other Income / (Expense), net		 -0.86 0.53 -2.35 0.55 1.37 -0.88 0.01 0.97 -1.66 -0.16 0.25
Interest Expense		 0.70 0.69 0.82 1.00 0.82 0.80 0.83 1.31 1.30 1.17 1.12
Interest & Investment Income		 0.72 1.06 1.07 0.95 1.54 1.39 1.44 0.97 0.48 0.45 0.62
Other Income / (Expense), net		 -0.87 0.17 -2.61 0.59 0.66 -1.46 -0.60 1.31 -0.84 0.56 0.75
Income Tax Expense		 5.83 4.37 3.18 4.77 2.31 2.54 3.06 3.76 3.74 2.76 4.46
Basic Earnings per Share		 $0.47 $0.58 $0.41 $0.45 $0.49 $0.36 $0.48 $0.62 $0.45 $0.45 $0.62
Weighted Average Basic Shares Outstanding		 31.97M 31.63M 31.49M 31.30M 31.36M 30.74M 30.51M 30.30M 30.41M 30.01M 29.74M
Diluted Earnings per Share		 $0.46 $0.58 $0.41 $0.44 $0.49 $0.36 $0.48 $0.61 $0.44 $0.44 $0.62
Weighted Average Diluted Shares Outstanding		 32.24M 31.89M 31.69M 31.51M 31.58M 30.99M 30.73M 30.54M 30.72M 30.33M 29.99M
Weighted Average Basic & Diluted Shares Outstanding		 31.67M 31.54M 31.36M 31.16M 30.79M 30.57M 30.37M 30.12M 30.04M 29.84M 29.48M
Cash Dividends to Common per Share		 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04 $0.04

Annual Cash Flow Statements for CTS

This table details how cash moves in and out of CTS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 10 22 -43 -0.23 -13 -0.69 -8.47 50 15 6.97 -70
Net Cash From Operating Activities		 33 39 47 58 58 64 77 86 121 89 99
Net Cash From Continuing Operating Activities		 33 39 47 58 58 64 77 86 121 89 99
Net Income / (Loss) Continuing Operations		 27 6.95 34 14 47 36 35 -42 60 61 58
Consolidated Net Income / (Loss)		 27 6.95 34 14 47 36 35 -42 60 61 58
Depreciation Expense		 17 16 19 21 23 25 27 27 30 29 31
Non-Cash Adjustments To Reconcile Net Income		 6.69 24 -8.75 17 5.60 8.11 8.77 140 11 3.23 12
Changes in Operating Assets and Liabilities, net		 -15 -5.47 4.18 6.37 -16 -4.47 6.65 -39 21 -3.66 -1.36
Net Cash From Investing Activities		 -8.00 -9.13 -81 -37 -28 -96 -23 -16 -111 -18 -141
Net Cash From Continuing Investing Activities		 -8.00 -9.13 -81 -37 -28 -96 -23 -16 -111 -18 -141
Purchase of Property, Plant & Equipment		 -13 -9.72 -21 -18 -28 -22 -15 -16 -14 -15 -19
Acquisitions		 0.00 -1.29 -73 -19 0.00 -74 -8.31 -0.26 -97 -3.36 -122
Net Cash From Financing Activities		 -16 -7.83 -8.64 -21 -42 30 -61 -21 4.34 -65 -28
Net Cash From Continuing Financing Activities		 -16 -7.83 -8.64 -21 -42 30 -61 -21 4.34 -65 -28
Repayment of Debt		 -1,034 -1,344 -2,458 -1,519 -1,060 -1,886 -3,793 -809 -723 -775 -892
Repurchase of Common Equity		 -8.00 -18 0.00 0.00 -9.44 -12 -8.08 -8.79 -21 -41 -43
Payment of Dividends		 -5.37 -5.29 -5.23 -5.26 -5.29 -5.24 -5.18 -5.17 -5.13 -5.04 -4.89
Issuance of Debt		 1,031 1,359 2,457 1,505 1,034 1,936 3,747 804 757 758 916
Other Financing Activities, net		 0.58 -0.15 -1.81 -1.60 -1.47 -2.66 -2.97 -2.15 -2.72 -3.26 -4.21
Effect of Exchange Rate Changes		 0.72 0.23 -0.42 -0.79 0.19 0.35 -0.75 0.16 1.10 1.65 -0.34
Cash Interest Paid		 2.11 2.42 2.94 2.13 1.58 1.96 2.60 1.95 2.02 3.13 4.23
Cash Income Taxes Paid		 7.99 6.78 10 11 9.92 11 12 17 20 20 17

Quarterly Cash Flow Statements for CTS

This table details how cash moves in and out of CTS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents		 9.00 -13 7.34 9.23 3.76 -1.45 -1.18 -66 -0.54 -4.05 9.15
Net Cash From Operating Activities		 25 11 23 22 32 18 20 35 26 16 28
Net Cash From Continuing Operating Activities		 25 11 23 22 32 18 20 35 26 16 28
Net Income / (Loss) Continuing Operations		 15 18 13 14 15 11 15 19 14 13 19
Consolidated Net Income / (Loss)		 15 18 13 14 15 11 15 19 14 13 19
Depreciation Expense		 8.03 6.92 7.26 7.25 7.29 7.33 7.33 7.99 8.28 8.49 8.55
Non-Cash Adjustments To Reconcile Net Income		 2.54 2.64 2.28 -3.37 1.68 2.14 0.29 4.74 4.45 2.31 1.37
Changes in Operating Assets and Liabilities, net		 -0.04 -17 0.99 4.28 7.78 -2.27 -2.70 3.99 -0.38 -8.65 -0.09
Net Cash From Investing Activities		 -5.40 -7.90 -3.95 -2.75 -3.50 -4.04 -4.64 -126 -6.10 -4.47 -3.28
Net Cash From Continuing Investing Activities		 -5.40 -7.90 -3.95 -2.75 -3.50 -4.04 -4.64 -126 -6.10 -4.47 -3.28
Purchase of Property, Plant & Equipment		 -5.07 -4.54 -3.95 -2.75 -3.50 -4.04 -4.64 -3.87 -6.10 -4.47 -3.28
Net Cash From Financing Activities		 -11 -17 -13 -9.97 -25 -16 -16 25 -20 -16 -16
Net Cash From Continuing Financing Activities		 -11 -17 -13 -9.97 -25 -16 -16 25 -20 -16 -16
Repayment of Debt		 -205 -204 -46 -344 -181 -168 -168 -266 -291 -264 -278
Repurchase of Common Equity		 -8.00 -8.80 -8.76 -8.33 -15 -12 -11 -12 -7.81 -6.47 -17
Payment of Dividends		 -1.28 -1.27 -1.26 -1.26 -1.25 -1.23 -1.23 -1.22 -1.21 -1.20 -1.20
Issuance of Debt		 203 201 42 343 172 168 165 303 280 259 279
Other Financing Activities, net		 -0.17 -3.14 -0.10 -0.01 -0.01 -3.12 -1.09 -0.02 0.02 -2.63 -0.02
Effect of Exchange Rate Changes		 0.23 -0.04 1.21 -0.18 0.66 0.58 -0.42 -0.55 0.05 0.80 0.53
Cash Interest Paid		 0.50 0.93 0.79 0.63 0.78 0.74 0.82 1.22 1.45 1.06 1.11
Cash Income Taxes Paid		 7.47 4.20 5.53 5.40 5.11 3.80 4.27 4.08 4.46 2.91 4.18

Annual Balance Sheets for CTS

This table presents CTS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 457 483 518 540 548 643 626 664 748 741 765
Total Current Assets		 240 246 216 234 239 237 233 289 326 319 242
Cash & Equivalents		 135 157 114 114 101 100 92 141 157 164 94
Accounts Receivable		 57 55 63 71 80 78 81 82 91 79 78
Inventories, net		 28 25 29 37 43 42 46 50 62 60 52
Other Current Assets		 21 9.86 11 13 15 17 15 16 16 17 18
Plant, Property, & Equipment, net		 71 70 82 88 99 105 97 97 97 93 94
Total Noncurrent Assets		 145 168 220 218 210 301 295 278 325 329 429
Goodwill		 32 34 62 71 71 106 109 110 152 158 201
Intangible Assets		 37 35 64 67 60 85 79 70 108 104 164
Noncurrent Deferred & Refundable Income Taxes		 43 64 46 21 22 20 24 25 23 25 28
Employee Benefit Assets		 32 34 46 57 54 62 57 49 0.00 0.00 0.00
Other Noncurrent Operating Assets		 1.25 1.34 1.74 2.10 2.04 28 26 24 42 42 36
Total Liabilities & Shareholders' Equity		 457 483 518 540 548 643 626 664 748 741 765
Total Liabilities		 167 202 200 196 170 238 202 201 242 214 237
Total Current Liabilities		 80 95 98 102 104 97 105 114 113 97 98
Accounts Payable		 43 40 40 49 52 48 50 56 53 43 43
Accrued Expenses		 25 47 46 41 37 36 38 37 35 35 35
Current Employee Benefit Liabilities		 11 7.15 11 12 15 9.56 13 18 20 15 16
Other Current Liabilities		 - - - - 0.00 2.79 3.29 3.39 3.94 4.39 4.72
Total Noncurrent Liabilities		 87 107 102 93 66 141 97 87 130 117 139
Long-Term Debt		 75 91 89 76 50 100 55 50 84 68 92
Noncurrent Deferred & Payable Income Tax Liabilities		 - - 2.37 3.80 3.99 5.64 7.01 5.89 16 15 13
Noncurrent Employee Benefit Liabilities		 - - - - - 6.63 7.47 6.89 5.05 4.66 3.93
Other Noncurrent Operating Liabilities		 9.11 9.17 3.21 6.18 5.92 29 28 24 25 30 30
Commitments & Contingencies		 - - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 290 282 318 344 378 405 424 464 506 527 528
Total Preferred & Common Equity		 290 282 318 344 378 405 424 464 506 527 528
Total Common Equity		 290 282 318 344 378 405 424 464 506 527 528
Common Stock		 339 342 343 346 350 352 353 357 363 364 367
Retained Earnings		 380 382 411 420 479 510 539 492 547 602 653
Treasury Stock		 -325 -343 -343 -343 -353 -364 -373 -381 -403 -444 -487
Accumulated Other Comprehensive Income / (Loss)		 -104 -99 -93 -79 -98 -92 -96 -4.53 -0.67 4.26 -4.27

Quarterly Balance Sheets for CTS

This table presents CTS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025
Total Assets		 730 735 747 756 754 733 726 789 766 785
Total Current Assets		 279 326 323 330 334 318 315 256 244 262
Cash & Equivalents		 99 148 144 151 160 162 161 95 90 99
Accounts Receivable		 99 97 98 98 90 81 85 86 81 86
Inventories, net		 64 63 63 63 65 58 52 57 54 57
Other Current Assets		 17 18 18 19 19 17 17 17 18 20
Plant, Property, & Equipment, net		 100 96 96 95 93 92 92 93 94 94
Total Noncurrent Assets		 351 312 328 331 327 323 319 440 428 429
Goodwill		 140 139 156 156 154 156 156 195 203 208
Intangible Assets		 113 106 110 109 104 100 97 181 162 162
Noncurrent Deferred & Refundable Income Taxes		 23 23 23 23 24 26 27 27 28 27
Employee Benefit Assets		 34 0.01 - 0.00 0.00 - 0.00 0.00 - 0.00
Other Noncurrent Operating Assets		 42 44 39 44 45 41 39 38 35 33
Total Liabilities & Shareholders' Equity		 730 735 747 756 754 733 726 789 766 785
Total Liabilities		 244 244 233 235 231 212 203 259 227 235
Total Current Liabilities		 115 122 106 107 103 96 92 104 92 100
Accounts Payable		 61 66 53 53 50 46 41 45 43 47
Accrued Expenses		 36 36 37 35 36 33 32 37 32 31
Current Employee Benefit Liabilities		 15 17 12 14 13 13 15 17 13 17
Other Current Liabilities		 3.61 3.53 4.03 4.29 4.44 4.40 4.37 4.59 4.34 4.56
Total Noncurrent Liabilities		 128 122 127 127 128 116 110 155 135 134
Long-Term Debt		 91 85 80 77 77 68 65 103 87 88
Noncurrent Deferred & Payable Income Tax Liabilities		 6.17 5.52 16 16 15 14 14 14 13 14
Noncurrent Employee Benefit Liabilities		 6.36 6.25 5.02 5.02 4.96 4.62 4.58 4.56 3.91 3.87
Other Noncurrent Operating Liabilities		 25 25 26 29 31 29 27 34 31 28
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 486 491 514 521 523 521 523 531 538 550
Total Preferred & Common Equity		 486 491 514 521 523 521 523 531 538 550
Total Common Equity		 486 491 514 521 523 521 523 531 538 550
Common Stock		 359 361 361 363 364 362 363 365 365 366
Retained Earnings		 523 533 564 575 588 612 626 643 665 682
Treasury Stock		 -393 -395 -412 -420 -429 -456 -467 -479 -493 -510
Accumulated Other Comprehensive Income / (Loss)		 -2.67 -8.85 0.70 3.69 -0.68 2.94 0.78 2.02 1.27 12

Annual Metrics And Ratios for CTS

This table displays calculated financial ratios and metrics derived from CTS's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -1.33% -5.37% 3.76% 6.63% 11.23% -0.32% -9.58% 20.95% 14.42% -6.21% -6.30%
EBITDA Growth		 9.92% -52.18% 200.69% -18.24% 28.40% -6.28% -1.88% -143.94% 440.76% -7.89% -0.46%
EBIT Growth		 100.19% -69.62% 404.76% -29.06% 37.93% -12.31% -6.79% -224.96% 236.90% -9.49% -3.63%
NOPAT Growth		 1,358.87% -63.99% 269.28% -63.58% 253.79% -20.83% -11.06% 55.54% 28.19% -11.92% -1.76%
Net Income Growth		 775.03% -73.78% 394.39% -57.98% 222.07% -22.32% -4.04% -220.70% 242.30% 1.61% -3.99%
EPS Growth		 750.00% -73.08% 390.48% -58.25% 223.26% -21.58% -2.75% -222.64% 242.31% 3.78% -1.56%
Operating Cash Flow Growth		 -11.24% 17.40% 20.56% 22.98% 0.18% 10.75% 19.22% 12.19% 40.70% -26.72% 11.80%
Free Cash Flow Firm Growth		 -31.19% -44.90% -262.45% 103.59% 1,837.25% -237.17% 234.90% 29.18% -88.58% 712.00% -160.23%
Invested Capital Growth		 -6.90% -6.45% 36.56% 4.20% 6.68% 23.76% -4.49% -3.72% 16.36% -0.59% 22.61%
Revenue Q/Q Growth		 -0.49% -1.82% 2.14% 2.25% 1.99% -1.06% 1.92% 1.89% 1.69% -3.10% 0.53%
EBITDA Q/Q Growth		 -10.59% -31.26% 18.35% -14.36% 25.71% -3.91% 9.89% -17.38% 6.66% -4.28% 2.25%
EBIT Q/Q Growth		 5.78% -43.82% 27.40% -20.92% 37.73% -6.40% 15.55% -8.53% 7.40% -4.95% 1.79%
NOPAT Q/Q Growth		 -22.95% -62.63% 176.40% -62.87% 199.51% -17.62% 11.42% 1.73% 6.12% -2.16% 1.34%
Net Income Q/Q Growth		 29.24% -70.57% 176.88% -60.28% 203.20% -17.19% 16.40% -16.03% 10.73% 0.63% -2.87%
EPS Q/Q Growth		 59.18% -16.00% 45.07% -67.42% 215.91% -17.42% 15.22% -16.07% 11.45% 1.59% -2.58%
Operating Cash Flow Q/Q Growth		 21.63% -7.06% -3.86% -3.42% 8.41% 14.34% 5.23% -1.67% -0.46% 8.04% -5.80%
Free Cash Flow Firm Q/Q Growth		 -41.22% -52.66% -5.31% -88.06% 328.84% -4.60% 7.19% 9.03% -49.41% 24.12% 7.04%
Invested Capital Q/Q Growth		 -11.75% -8.47% 2.21% -1.99% 1.41% -0.50% -0.52% -1.78% 1.12% -2.00% -2.02%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 32.17% 33.25% 35.40% 33.20% 35.06% 33.60% 32.79% 35.99% 35.87% 34.68% 36.67%
EBITDA Margin		 13.26% 6.70% 19.42% 14.89% 17.19% 16.16% 17.54% -6.37% 18.97% 18.63% 19.80%
Operating Margin		 10.48% 4.74% 15.92% 9.10% 12.97% 11.47% 10.64% 14.91% 15.85% 13.64% 14.11%
EBIT Margin		 9.63% 3.09% 15.04% 10.00% 12.40% 10.91% 11.25% -11.62% 13.90% 13.42% 13.80%
Profit (Net Income) Margin		 6.56% 1.82% 8.67% 3.42% 9.89% 7.71% 8.18% -8.16% 10.15% 11.00% 11.27%
Tax Burden Percent		 67.40% 56.72% 60.06% 35.89% 80.09% 71.91% 76.27% 68.77% 73.79% 80.55% 81.59%
Interest Burden Percent		 101.18% 103.77% 95.98% 95.13% 99.56% 98.22% 95.34% 102.13% 98.94% 101.75% 100.06%
Effective Tax Rate		 32.60% 43.28% 39.94% 64.11% 19.91% 28.09% 23.73% 0.00% 26.21% 19.46% 18.41%
Return on Invested Capital (ROIC)		 11.95% 4.61% 14.89% 4.60% 15.43% 10.58% 8.70% 14.11% 17.05% 14.00% 12.39%
ROIC Less NNEP Spread (ROIC-NNEP)		 15.63% 9.89% 22.80% 2.53% 20.76% 20.49% 7.29% 162.44% 28.04% 13.91% 14.95%
Return on Net Nonoperating Assets (RNNOA)		 -2.90% -2.18% -3.42% -0.23% -2.54% -1.35% -0.33% -23.55% -4.76% -2.28% -1.41%
Return on Equity (ROE)		 9.04% 2.43% 11.47% 4.37% 12.89% 9.23% 8.37% -9.44% 12.29% 11.72% 10.99%
Cash Return on Invested Capital (CROIC)		 19.10% 11.28% -16.02% 0.49% 8.97% -10.66% 13.29% 17.91% 1.93% 14.59% -7.92%
Operating Return on Assets (OROA)		 8.30% 2.51% 11.92% 8.00% 10.73% 8.59% 7.52% -9.24% 11.55% 9.92% 9.44%
Return on Assets (ROA)		 5.66% 1.48% 6.87% 2.73% 8.55% 6.07% 5.46% -6.49% 8.43% 8.13% 7.71%
Return on Common Equity (ROCE)		 9.04% 2.43% 11.47% 4.37% 12.89% 9.23% 8.37% -9.44% 12.29% 11.72% 10.99%
Return on Equity Simple (ROE_SIMPLE)		 9.15% 2.47% 10.82% 4.20% 12.31% 8.92% 8.19% -9.03% 11.77% 11.49% 10.95%
Net Operating Profit after Tax (NOPAT)		 29 10 38 14 49 39 34 54 69 60 59
NOPAT Margin		 7.06% 2.69% 9.56% 3.27% 10.39% 8.25% 8.12% 10.44% 11.69% 10.98% 11.51%
Net Nonoperating Expense Percent (NNEP)		 -3.68% -5.28% -7.91% 2.07% -5.33% -9.92% 1.42% -148.33% -10.99% 0.10% -2.55%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 11.63% 10.17% 9.55%
Cost of Revenue to Revenue		 67.83% 66.75% 64.60% 66.80% 64.94% 66.40% 67.21% 64.01% 64.13% 65.33% 63.33%
SG&A Expenses to Revenue		 15.11% 15.59% 15.54% 17.01% 15.64% 15.01% 15.99% 16.10% 15.59% 15.23% 17.12%
R&D to Revenue		 5.58% 5.88% 6.06% 5.94% 5.38% 5.54% 5.73% 4.65% 4.11% 4.53% 4.53%
Operating Expenses to Revenue		 21.69% 28.51% 19.48% 24.10% 22.09% 22.12% 22.15% 21.08% 20.03% 21.04% 22.56%
Earnings before Interest and Taxes (EBIT)		 39 12 60 42 58 51 48 -60 82 74 71
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 54 26 77 63 81 76 74 -33 111 103 102
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.95 1.95 2.22 2.39 2.21 2.36 2.58 2.53 2.47 2.58 2.99
Price to Tangible Book Value (P/TBV)		 2.55 2.58 3.68 3.99 3.38 4.48 4.65 4.13 5.08 5.12 9.50
Price to Revenue (P/Rev)		 1.40 1.44 1.78 1.94 1.77 2.04 2.58 2.28 2.13 2.47 3.08
Price to Earnings (P/E)		 21.28 78.97 20.54 56.87 17.93 26.50 31.49 0.00 20.95 22.44 27.33
Dividend Yield		 0.95% 0.95% 0.74% 0.64% 0.63% 0.54% 0.59% 0.44% 0.41% 0.37% 0.30%
Earnings Yield		 4.70% 1.27% 4.87% 1.76% 5.58% 3.77% 3.18% 0.00% 4.77% 4.46% 3.66%
Enterprise Value to Invested Capital (EV/IC)		 2.19 2.24 2.32 2.56 2.40 2.37 2.73 2.90 2.71 2.93 3.00
Enterprise Value to Revenue (EV/Rev)		 1.25 1.26 1.72 1.85 1.67 2.04 2.49 2.11 2.00 2.29 3.07
Enterprise Value to EBITDA (EV/EBITDA)		 9.42 18.85 8.86 12.45 9.69 12.63 14.18 0.00 10.55 12.30 15.52
Enterprise Value to EBIT (EV/EBIT)		 12.98 40.87 11.44 18.54 13.42 18.71 22.11 0.00 14.40 17.09 22.27
Enterprise Value to NOPAT (EV/NOPAT)		 17.70 47.01 17.99 56.77 16.03 24.74 30.65 20.18 17.12 20.88 26.69
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.14 12.34 14.46 13.51 13.47 14.87 13.74 12.54 9.69 14.21 15.96
Enterprise Value to Free Cash Flow (EV/FCFF)		 11.07 19.22 0.00 534.72 27.57 0.00 20.06 15.91 151.43 20.04 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.26 0.32 0.28 0.22 0.13 0.25 0.13 0.11 0.17 0.13 0.17
Long-Term Debt to Equity		 0.26 0.32 0.28 0.22 0.13 0.25 0.13 0.11 0.17 0.13 0.17
Financial Leverage		 -0.19 -0.22 -0.15 -0.09 -0.12 -0.07 -0.05 -0.15 -0.17 -0.16 -0.09
Leverage Ratio		 1.60 1.65 1.67 1.60 1.51 1.52 1.53 1.45 1.46 1.44 1.43
Compound Leverage Factor		 1.62 1.71 1.60 1.52 1.50 1.49 1.46 1.49 1.44 1.47 1.43
Debt to Total Capital		 20.56% 24.36% 22.09% 18.16% 11.68% 19.75% 11.42% 9.74% 14.18% 11.36% 14.67%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 20.56% 24.36% 21.84% 18.16% 11.68% 19.75% 11.42% 9.74% 14.18% 11.36% 14.67%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 79.44% 75.64% 77.91% 81.84% 88.32% 80.25% 88.58% 90.26% 85.82% 88.64% 85.33%
Debt to EBITDA		 1.40 3.54 1.17 1.21 0.62 1.32 0.73 -1.53 0.75 0.66 0.89
Net Debt to EBITDA		 -1.11 -2.59 -0.31 -0.59 -0.63 -0.01 -0.50 2.80 -0.66 -0.94 -0.03
Long-Term Debt to EBITDA		 1.40 3.54 1.16 1.21 0.62 1.32 0.73 -1.53 0.75 0.66 0.89
Debt to NOPAT		 2.63 8.83 2.38 5.52 1.02 2.58 1.59 0.93 1.22 1.12 1.54
Net Debt to NOPAT		 -2.09 -6.45 -0.62 -2.70 -1.04 -0.01 -1.08 -1.71 -1.07 -1.59 -0.05
Long-Term Debt to NOPAT		 2.63 8.83 2.35 5.52 1.02 2.58 1.59 0.93 1.22 1.12 1.54
Altman Z-Score		 4.78 3.99 4.65 4.94 5.67 4.78 5.62 5.33 5.60 6.37 6.46
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.01 2.60 2.20 2.28 2.30 2.45 2.22 2.53 2.89 3.29 2.50
Quick Ratio		 2.39 2.24 1.80 1.80 1.74 1.84 1.65 1.96 2.20 2.50 1.76
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 46 25 -41 1.47 28 -39 53 68 7.76 63 -38
Operating Cash Flow to CapEx		 416.97% 499.06% 575.35% 330.70% 204.15% 298.23% 516.78% 550.74% 845.58% 602.60% 532.55%
Free Cash Flow to Firm to Interest Expense		 19.61 9.56 -11.03 0.44 13.63 -14.72 16.07 32.18 3.54 18.91 -8.96
Operating Cash Flow to Interest Expense		 14.34 14.90 12.75 17.36 27.89 24.32 23.47 40.81 55.29 26.66 23.44
Operating Cash Flow Less CapEx to Interest Expense		 10.90 11.91 10.53 12.11 14.23 16.17 18.93 33.40 48.75 22.24 19.04
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.86 0.81 0.79 0.80 0.86 0.79 0.67 0.79 0.83 0.74 0.68
Accounts Receivable Turnover		 6.76 6.86 6.77 6.35 6.27 5.95 5.33 6.29 6.78 6.49 6.60
Inventory Turnover		 9.12 9.72 9.62 8.66 7.63 7.27 6.47 6.88 6.73 5.88 5.75
Fixed Asset Turnover		 5.52 5.41 5.22 4.97 5.01 4.59 4.19 5.28 6.04 5.80 5.52
Accounts Payable Turnover		 6.06 6.10 6.38 6.33 6.04 6.22 5.77 6.19 6.92 7.44 7.58
Days Sales Outstanding (DSO)		 54.01 53.21 53.91 57.47 58.22 61.30 68.42 58.06 53.84 56.20 55.28
Days Inventory Outstanding (DIO)		 40.03 37.53 37.93 42.14 47.84 50.24 56.42 53.02 54.20 62.07 63.48
Days Payable Outstanding (DPO)		 60.20 59.81 57.22 57.64 60.44 58.72 63.21 58.94 52.74 49.09 48.12
Cash Conversion Cycle (CCC)		 33.84 30.93 34.61 41.97 45.62 52.82 61.63 52.14 55.30 69.19 70.63
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 230 215 294 307 327 405 387 372 433 430 528
Invested Capital Turnover		 1.69 1.72 1.56 1.41 1.49 1.28 1.07 1.35 1.46 1.28 1.08
Increase / (Decrease) in Invested Capital		 -17 -15 79 12 20 78 -18 -14 61 -2.54 97
Enterprise Value (EV)		 505 483 682 784 783 957 1,055 1,081 1,175 1,262 1,585
Market Capitalization		 564 549 706 822 834 958 1,092 1,172 1,248 1,358 1,588
Book Value per Share		 $8.66 $8.63 $9.70 $10.44 $11.42 $12.43 $13.13 $14.39 $15.88 $16.91 $17.63
Tangible Book Value per Share		 $6.61 $6.53 $5.85 $6.25 $7.46 $6.56 $7.28 $8.81 $7.71 $8.51 $5.55
Total Capital		 365 372 408 420 428 505 478 514 590 594 622
Total Debt		 75 91 90 76 50 100 55 50 84 68 91
Total Long-Term Debt		 75 91 89 76 50 100 55 50 84 68 91
Net Debt		 -60 -66 -24 -37 -51 -0.54 -37 -91 -73 -96 -3.08
Capital Expenditures (CapEx)		 8.00 7.85 8.20 18 28 22 15 16 14 15 19
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 26 -5.59 4.78 18 34 40 37 34 56 58 52
Debt-free Net Working Capital (DFNWC)		 160 151 119 131 135 141 128 175 213 222 147
Net Working Capital (NWC)		 160 151 118 131 135 141 128 175 213 222 147
Net Nonoperating Expense (NNE)		 2.01 3.32 3.56 -0.63 2.35 2.55 -0.27 95 9.05 -0.08 1.27
Net Nonoperating Obligations (NNO)		 -60 -66 -24 -37 -51 -0.54 -37 -91 -73 -96 -3.08
Total Depreciation and Amortization (D&A)		 15 14 17 21 23 25 27 27 30 29 31
Debt-free, Cash-free Net Working Capital to Revenue		 6.41% -1.46% 1.20% 4.17% 7.32% 8.59% 8.61% 6.54% 9.60% 10.62% 10.16%
Debt-free Net Working Capital to Revenue		 39.71% 39.58% 29.89% 31.02% 28.77% 29.96% 30.25% 34.12% 36.33% 40.39% 28.45%
Net Working Capital to Revenue		 39.71% 39.58% 29.64% 31.02% 28.77% 29.96% 30.25% 34.12% 36.33% 40.39% 28.45%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.79 $0.21 $1.05 $0.44 $1.41 $1.11 $1.07 ($1.30) $1.86 $1.93 $1.91
Adjusted Weighted Average Basic Shares Outstanding		 33.62M 32.96M 32.73M 32.89M 33.02M 32.70M 32.32M 32.33M 31.97M 31.36M 30.41M
Adjusted Diluted Earnings per Share		 $0.78 $0.21 $1.03 $0.43 $1.39 $1.09 $1.06 ($1.30) $1.85 $1.92 $1.89
Adjusted Weighted Average Diluted Shares Outstanding		 34.13M 33.48M 33.25M 33.42M 33.57M 33.11M 32.58M 32.33M 32.24M 31.58M 30.72M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 33.44M 32.58M 32.76M 32.94M 32.73M 64.87M 32.35M 32.15M 31.67M 30.79M 30.04M
Normalized Net Operating Profit after Tax (NOPAT)		 31 26 33 30 53 44 36 55 70 66 63
Normalized NOPAT Margin		 7.73% 6.69% 8.29% 7.17% 11.25% 9.38% 8.45% 10.67% 11.93% 12.02% 12.26%
Pre Tax Income Margin		 9.74% 3.21% 14.43% 9.52% 12.35% 10.72% 10.72% -11.87% 13.76% 13.65% 13.81%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 16.72 4.50 16.11 12.66 27.99 19.33 14.58 -28.24 37.23 22.17 16.80
NOPAT to Interest Expense		 12.26 3.91 10.25 4.13 23.44 14.61 10.52 25.36 31.31 18.15 14.02
EBIT Less CapEx to Interest Expense		 13.28 1.51 13.89 7.41 14.33 11.17 10.04 -35.65 30.69 17.75 12.40
NOPAT Less CapEx to Interest Expense		 8.83 0.92 8.03 -1.12 9.78 6.46 5.98 17.95 24.77 13.72 9.62
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 20.26% 76.09% 15.22% 36.41% 11.36% 14.49% 14.93% -12.36% 8.61% 8.33% 8.41%
Augmented Payout Ratio		 50.43% 336.20% 15.22% 36.41% 31.64% 46.99% 38.23% -33.34% 44.61% 75.94% 81.70%

Quarterly Metrics And Ratios for CTS

This table displays calculated financial ratios and metrics derived from CTS's official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 7.36% -1.15% 0.14% -11.43% -12.36% -13.87% -10.35% -1.58% 2.20% 0.02% 3.95%
EBITDA Growth		 31.83% -10.96% -4.92% 2.35% -15.94% -30.28% 6.08% 18.22% 9.27% 24.21% 30.81%
EBIT Growth		 37.15% -14.45% -8.31% 7.49% -18.53% -41.48% 8.44% 21.29% 7.40% 28.83% 36.83%
NOPAT Growth		 35.83% -12.51% -12.47% -12.19% -9.19% -33.94% -0.55% 31.80% 5.49% 14.10% 24.63%
Net Income Growth		 63.01% -9.36% 2.37% 18.42% 2.54% -39.39% 14.03% 33.73% -11.19% 20.22% 25.97%
EPS Growth		 70.37% -7.94% 5.13% 18.92% 6.52% -37.93% 17.07% 38.64% -10.20% 22.22% 29.17%
Operating Cash Flow Growth		 -2.17% -42.00% 45.78% -63.34% 25.97% 63.70% -16.19% 59.91% -19.07% -15.25% 44.44%
Free Cash Flow Firm Growth		 -275.29% -2,190.52% 161.08% 107.45% 136.78% 225.78% -21.35% -3,330.92% -594.52% -360.88% -362.59%
Invested Capital Growth		 16.36% 11.58% -6.41% 2.58% -0.59% -5.43% -4.70% 22.63% 22.61% 25.40% 26.31%
Revenue Q/Q Growth		 -6.34% 2.61% -0.56% -7.32% -7.33% 0.85% 3.51% 1.74% -3.77% -1.31% 7.59%
EBITDA Q/Q Growth		 13.16% 1.65% -21.11% 12.78% -7.05% -15.70% 20.05% 25.67% -14.08% -4.18% 26.43%
EBIT Q/Q Growth		 18.79% 7.63% -29.16% 18.68% -9.96% -22.70% 31.27% 32.75% -20.28% -7.27% 39.42%
NOPAT Q/Q Growth		 0.74% 15.14% -17.47% -8.26% 4.18% -16.24% 24.24% 21.57% -16.62% -9.40% 35.72%
Net Income Q/Q Growth		 26.63% 22.78% -29.69% 8.33% 9.66% -27.42% 32.27% 27.03% -27.18% -1.75% 38.60%
EPS Q/Q Growth		 24.32% 26.09% -29.31% 7.32% 11.36% -26.53% 33.33% 27.08% -27.87% 0.00% 40.91%
Operating Cash Flow Q/Q Growth		 -57.84% -56.06% 109.38% -5.49% 44.88% -42.90% 7.20% 80.32% -26.67% -40.21% 82.70%
Free Cash Flow Firm Q/Q Growth		 -33.70% 36.25% 257.37% -94.45% 560.41% 118.01% -1.59% -328.04% -1.08% -15.01% 0.95%
Invested Capital Q/Q Growth		 1.12% 4.13% -0.73% -1.86% -2.00% -0.95% 0.03% 26.29% -2.02% 1.30% 0.76%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 35.85% 35.38% 34.95% 34.49% 33.73% 35.86% 35.63% 37.60% 37.59% 37.01% 38.75%
EBITDA Margin		 20.23% 20.04% 15.90% 19.35% 19.40% 16.22% 18.81% 23.24% 20.75% 20.14% 23.67%
Operating Margin		 15.20% 15.19% 12.70% 13.52% 13.04% 11.56% 13.65% 16.22% 14.91% 12.95% 16.80%
EBIT Margin		 14.59% 15.30% 10.90% 13.96% 13.56% 10.40% 13.18% 17.20% 14.25% 13.39% 17.35%
Profit (Net Income) Margin		 10.50% 12.56% 8.88% 10.38% 12.29% 8.84% 11.30% 14.11% 10.68% 10.63% 13.69%
Tax Burden Percent		 71.93% 80.78% 80.21% 74.56% 86.91% 81.41% 82.77% 83.23% 78.42% 82.91% 80.62%
Interest Burden Percent		 100.07% 101.65% 101.61% 99.76% 104.23% 104.47% 103.54% 98.53% 95.52% 95.73% 97.87%
Effective Tax Rate		 28.07% 19.22% 19.79% 25.44% 13.09% 18.59% 17.23% 16.77% 21.58% 17.09% 19.38%
Return on Invested Capital (ROIC)		 15.94% 16.80% 12.88% 13.20% 14.45% 11.38% 13.32% 14.16% 12.59% 11.52% 14.62%
ROIC Less NNEP Spread (ROIC-NNEP)		 16.69% 16.18% 17.50% 12.64% 13.04% 12.28% 13.31% 12.02% 15.20% 11.80% 14.24%
Return on Net Nonoperating Assets (RNNOA)		 -2.83% -2.27% -1.42% -1.82% -2.14% -1.88% -2.17% -0.86% -1.43% -1.10% -1.43%
Return on Equity (ROE)		 13.11% 14.53% 11.46% 11.38% 12.30% 9.50% 11.15% 13.30% 11.16% 10.43% 13.19%
Cash Return on Invested Capital (CROIC)		 1.93% 4.53% 20.46% 11.70% 14.59% 17.98% 17.23% -8.35% -7.92% -9.83% -9.85%
Operating Return on Assets (OROA)		 12.12% 12.51% 8.59% 10.65% 10.02% 7.45% 9.17% 11.44% 9.75% 9.22% 11.97%
Return on Assets (ROA)		 8.72% 10.27% 7.00% 7.92% 9.08% 6.34% 7.86% 9.38% 7.31% 7.32% 9.45%
Return on Common Equity (ROCE)		 13.11% 14.53% 11.46% 11.38% 12.30% 9.50% 11.15% 13.30% 11.16% 10.43% 13.19%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 11.22% 11.12% 11.51% 0.00% 10.23% 10.54% 11.27% 0.00% 11.21% 11.67%
Net Operating Profit after Tax (NOPAT)		 16 18 15 14 14 12 15 18 15 14 18
NOPAT Margin		 10.93% 12.27% 10.18% 10.08% 11.33% 9.41% 11.30% 13.50% 11.70% 10.74% 13.54%
Net Nonoperating Expense Percent (NNEP)		 -0.75% 0.62% -4.63% 0.56% 1.41% -0.90% 0.00% 2.14% -2.61% -0.27% 0.38%
Return On Investment Capital (ROIC_SIMPLE)		 2.64% - - - 2.38% 2.01% - - 2.40% 2.16% 2.87%
Cost of Revenue to Revenue		 64.15% 64.62% 65.05% 65.51% 66.27% 64.14% 64.37% 62.40% 62.41% 62.99% 61.25%
SG&A Expenses to Revenue		 16.51% 15.05% 16.32% 13.87% 15.62% 17.70% 16.39% 17.00% 17.41% 18.78% 17.06%
R&D to Revenue		 3.80% 4.51% 4.63% 4.70% 4.24% 5.25% 4.68% 3.80% 4.45% 4.92% 4.68%
Operating Expenses to Revenue		 20.65% 20.19% 22.25% 20.97% 20.70% 24.30% 21.98% 21.38% 22.67% 24.06% 21.95%
Earnings before Interest and Taxes (EBIT)		 21 22 16 19 17 13 17 23 18 17 23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 29 29 23 26 24 20 24 31 26 25 32
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.47 3.03 2.57 2.50 2.58 2.79 2.96 2.77 2.99 2.32 2.31
Price to Tangible Book Value (P/TBV)		 5.08 6.27 5.22 4.93 5.12 5.48 5.74 9.47 9.50 7.22 7.03
Price to Revenue (P/Rev)		 2.13 2.66 2.29 2.30 2.47 2.74 3.00 2.86 3.08 2.42 2.44
Price to Earnings (P/E)		 20.95 27.03 23.11 21.68 22.44 27.26 28.08 24.55 27.33 20.68 19.81
Dividend Yield		 0.41% 0.33% 0.38% 0.38% 0.37% 0.34% 0.32% 0.33% 0.30% 0.39% 0.38%
Earnings Yield		 4.77% 3.70% 4.33% 4.61% 4.46% 3.67% 3.56% 4.07% 3.66% 4.84% 5.05%
Enterprise Value to Invested Capital (EV/IC)		 2.71 3.32 2.83 2.78 2.93 3.19 3.40 2.74 3.00 2.33 2.34
Enterprise Value to Revenue (EV/Rev)		 2.00 2.56 2.16 2.15 2.29 2.56 2.82 2.88 3.07 2.41 2.42
Enterprise Value to EBITDA (EV/EBITDA)		 10.55 13.88 11.88 11.39 12.30 14.49 15.26 14.79 15.52 11.63 11.00
Enterprise Value to EBIT (EV/EBIT)		 14.40 19.22 16.57 15.71 17.09 21.03 22.02 21.12 22.27 16.61 15.51
Enterprise Value to NOPAT (EV/NOPAT)		 17.12 22.61 19.77 19.76 20.88 24.98 26.75 25.20 26.69 20.39 19.49
Enterprise Value to Operating Cash Flow (EV/OCF)		 9.69 13.23 10.51 14.85 14.21 14.16 15.75 14.01 15.96 12.90 11.98
Enterprise Value to Free Cash Flow (EV/FCFF)		 151.43 77.23 13.37 24.06 20.04 17.22 19.27 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.17 0.16 0.15 0.15 0.13 0.13 0.12 0.19 0.17 0.16 0.16
Long-Term Debt to Equity		 0.17 0.16 0.15 0.15 0.13 0.13 0.12 0.19 0.17 0.16 0.16
Financial Leverage		 -0.17 -0.14 -0.08 -0.14 -0.16 -0.15 -0.16 -0.07 -0.09 -0.09 -0.10
Leverage Ratio		 1.46 1.44 1.47 1.47 1.44 1.43 1.42 1.47 1.43 1.41 1.41
Compound Leverage Factor		 1.46 1.46 1.50 1.47 1.50 1.49 1.47 1.44 1.36 1.35 1.38
Debt to Total Capital		 14.18% 13.50% 12.87% 12.79% 11.36% 11.46% 11.06% 16.21% 14.67% 13.87% 13.79%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 14.18% 13.50% 12.87% 12.79% 11.36% 11.46% 11.06% 16.21% 14.67% 13.87% 13.79%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 85.82% 86.50% 87.13% 87.21% 88.64% 88.54% 88.94% 83.79% 85.33% 86.13% 86.21%
Debt to EBITDA		 0.75 0.74 0.72 0.72 0.66 0.72 0.68 1.03 0.89 0.81 0.77
Net Debt to EBITDA		 -0.66 -0.59 -0.69 -0.78 -0.94 -1.01 -1.01 0.08 -0.03 -0.03 -0.10
Long-Term Debt to EBITDA		 0.75 0.74 0.72 0.72 0.66 0.72 0.68 1.03 0.89 0.81 0.77
Debt to NOPAT		 1.22 1.21 1.20 1.24 1.12 1.24 1.20 1.75 1.54 1.42 1.36
Net Debt to NOPAT		 -1.07 -0.96 -1.15 -1.35 -1.59 -1.75 -1.77 0.13 -0.05 -0.06 -0.18
Long-Term Debt to NOPAT		 1.22 1.21 1.20 1.24 1.12 1.24 1.20 1.75 1.54 1.42 1.36
Altman Z-Score		 5.33 6.30 5.69 5.68 6.12 6.44 6.94 5.53 6.23 5.49 5.48
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.89 3.05 3.08 3.23 3.29 3.32 3.41 2.46 2.50 2.63 2.61
Quick Ratio		 2.20 2.28 2.32 2.41 2.50 2.53 2.67 1.75 1.76 1.86 1.84
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -45 -29 45 2.52 17 36 36 -82 -82 -95 -94
Operating Cash Flow to CapEx		 501.83% 246.39% 593.39% 805.20% 915.73% 453.80% 423.31% 914.36% 425.41% 347.55% 864.39%
Free Cash Flow to Firm to Interest Expense		 -64.55 -41.62 55.58 2.53 20.28 45.36 42.92 -62.38 -63.64 -81.22 -83.75
Operating Cash Flow to Interest Expense		 36.27 16.12 28.63 22.20 39.01 22.86 23.56 27.08 20.04 13.30 25.29
Operating Cash Flow Less CapEx to Interest Expense		 29.04 9.58 23.81 19.44 34.75 17.82 18.00 24.12 15.33 9.47 22.37
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.83 0.82 0.79 0.76 0.74 0.72 0.70 0.66 0.68 0.69 0.69
Accounts Receivable Turnover		 6.78 6.07 5.96 6.09 6.49 5.94 5.63 5.83 6.60 6.36 6.09
Inventory Turnover		 6.73 6.51 5.98 5.72 5.88 5.71 5.87 5.38 5.75 5.82 5.96
Fixed Asset Turnover		 6.04 6.05 6.02 6.02 5.80 5.64 5.52 5.51 5.52 5.56 5.62
Accounts Payable Turnover		 6.92 6.65 6.66 6.37 7.44 6.99 7.13 6.96 7.58 7.32 7.36
Days Sales Outstanding (DSO)		 53.84 60.13 61.25 59.94 56.20 61.40 64.79 62.58 55.28 57.36 59.89
Days Inventory Outstanding (DIO)		 54.20 56.07 61.08 63.86 62.07 63.98 62.18 67.90 63.48 62.67 61.22
Days Payable Outstanding (DPO)		 52.74 54.86 54.84 57.26 49.09 52.25 51.16 52.47 48.12 49.83 49.60
Cash Conversion Cycle (CCC)		 55.30 61.35 67.49 66.54 69.19 73.13 75.81 78.00 70.63 70.19 71.51
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 433 451 448 439 430 426 427 539 528 535 539
Invested Capital Turnover		 1.46 1.37 1.26 1.31 1.28 1.21 1.18 1.05 1.08 1.07 1.08
Increase / (Decrease) in Invested Capital		 61 47 -31 11 -2.54 -25 -21 99 97 108 112
Enterprise Value (EV)		 1,175 1,496 1,266 1,221 1,262 1,358 1,451 1,477 1,585 1,245 1,260
Market Capitalization		 1,248 1,559 1,340 1,304 1,358 1,453 1,548 1,469 1,588 1,248 1,272
Book Value per Share		 $15.88 $16.24 $16.53 $16.67 $16.91 $16.96 $17.10 $17.48 $17.63 $17.92 $18.43
Tangible Book Value per Share		 $7.71 $7.86 $8.14 $8.44 $8.51 $8.62 $8.83 $5.11 $5.55 $5.76 $6.06
Total Capital		 590 594 598 599 594 589 588 634 622 625 638
Total Debt		 84 80 77 77 68 68 65 103 91 87 88
Total Long-Term Debt		 84 80 77 77 68 68 65 103 91 87 88
Net Debt		 -73 -63 -74 -83 -96 -95 -96 7.83 -3.08 -3.59 -11
Capital Expenditures (CapEx)		 5.07 4.54 3.95 2.75 3.50 4.04 4.64 3.87 6.10 4.47 3.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 56 73 72 71 58 60 61 57 52 61 62
Debt-free Net Working Capital (DFNWC)		 213 217 223 231 222 222 222 152 147 151 161
Net Working Capital (NWC)		 213 217 223 231 222 222 222 152 147 151 161
Net Nonoperating Expense (NNE)		 0.62 -0.43 1.89 -0.41 -1.19 0.71 -0.00 -0.81 1.30 0.14 -0.20
Net Nonoperating Obligations (NNO)		 -73 -63 -74 -83 -96 -95 -96 7.83 -3.08 -3.59 -11
Total Depreciation and Amortization (D&A)		 8.03 6.92 7.26 7.25 7.29 7.33 7.33 7.99 8.28 8.49 8.55
Debt-free, Cash-free Net Working Capital to Revenue		 9.60% 12.53% 12.27% 12.46% 10.62% 11.29% 11.87% 11.09% 10.16% 11.79% 11.87%
Debt-free Net Working Capital to Revenue		 36.33% 37.06% 38.04% 40.65% 40.39% 41.92% 43.17% 29.58% 28.45% 29.30% 30.96%
Net Working Capital to Revenue		 36.33% 37.06% 38.04% 40.65% 40.39% 41.92% 43.17% 29.58% 28.45% 29.30% 30.96%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.47 $0.58 $0.41 $0.45 $0.49 $0.36 $0.48 $0.62 $0.45 $0.45 $0.62
Adjusted Weighted Average Basic Shares Outstanding		 31.97M 31.63M 31.49M 31.30M 31.36M 30.74M 30.51M 30.30M 30.41M 30.01M 29.74M
Adjusted Diluted Earnings per Share		 $0.46 $0.58 $0.41 $0.44 $0.49 $0.36 $0.48 $0.61 $0.44 $0.44 $0.62
Adjusted Weighted Average Diluted Shares Outstanding		 32.24M 31.89M 31.69M 31.51M 31.58M 30.99M 30.73M 30.54M 30.72M 30.33M 29.99M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 31.67M 31.54M 31.36M 31.16M 30.79M 30.57M 30.37M 30.12M 30.04M 29.84M 29.48M
Normalized Net Operating Profit after Tax (NOPAT)		 16 19 16 16 15 13 16 19 16 14 19
Normalized NOPAT Margin		 11.18% 12.77% 11.23% 11.87% 12.06% 10.51% 12.05% 13.98% 12.34% 11.03% 13.72%
Pre Tax Income Margin		 14.60% 15.55% 11.08% 13.93% 14.14% 10.86% 13.65% 16.95% 13.61% 12.82% 16.98%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 29.57 32.19 19.35 18.84 20.57 16.32 20.60 17.43 14.02 14.43 20.95
NOPAT to Interest Expense		 22.16 25.81 18.07 13.60 17.19 14.77 17.65 13.68 11.51 11.57 16.35
EBIT Less CapEx to Interest Expense		 22.34 25.65 14.52 16.08 16.31 11.28 15.03 14.47 9.31 10.61 18.02
NOPAT Less CapEx to Interest Expense		 14.94 19.27 13.25 10.85 12.93 9.74 12.08 10.71 6.80 7.74 13.42
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 8.61% 8.87% 8.78% 8.43% 8.33% 9.38% 9.01% 8.23% 8.41% 8.04% 7.52%
Augmented Payout Ratio		 44.61% 54.51% 55.94% 64.77% 75.94% 92.08% 92.93% 91.51% 81.70% 69.51% 74.05%

Key Financial Trends

CTS Corporation Financial Overview (Q2 2022 – Q2 2025)

CTS has exhibited stable financial performance over the last four years, marked by consistent revenue growth, improving profitability, disciplined cash flow management, and a generally strong balance sheet. Below are key takeaways for retail investors:

  • Revenue Growth: Operating revenue increased from approximately $145 million in early 2022 to $135 million in Q2 2025, with some quarterly fluctuations typical in industrial sectors. The firm has managed to maintain revenues above $125 million each quarter in recent years, evidencing stable demand.
  • Profitability Gains: Net income improved from $12.6 million in Q2 2022 to $18.5 million in Q2 2025. Earnings per share rose from around $0.39 to $0.62 over this period, signaling enhanced profitability and operational efficiency.
  • Operating Cash Flow: Net cash from continuing operating activities consistently remained positive and increased from $16.1 million in Q2 2022 to $28.4 million in Q2 2025, indicating strong core earnings and effective working capital controls.
  • Investment in CapEx and Intangibles: CTS regularly invests approximately $3 million to $7 million quarterly in property, plant, and equipment, showing commitment to maintaining and growing its asset base. Intangible assets and goodwill have increased, reflecting strategic acquisitions and investments.
  • Capital Structure Improvements: The company has effectively managed its debt, issuing and repaying debt strategically, with long-term debt fluctuating but generally remaining controlled around $65 million to $88 million in recent periods. Repurchases of common equity and dividend payments demonstrate returning value to shareholders.
  • Quarterly Earnings Volatility: Some quarters such as Q3 2024 saw dips in net income and operating income, hinting at potential sensitivity to market or operational cycles which investors should monitor.
  • Consistent Dividend Policy: CTS has paid a steady dividend of $0.04 per share quarterly, indicating focus on shareholder returns, but also requiring sustained earnings and cash flow coverage.
  • Changes in Working Capital: Operating assets and liabilities show occasional fluctuations negatively impacting cash flow, such as significant changes in operating capital in Q1 2025 and Q1 2023, suggesting potential working capital management risks.
  • Large Investing Cash Outflows Due to Acquisitions: Notable investing cash flow impacts include multi-million acquisitions, for example, nearly $121 million in Q3 2024 and $75 million in Q2 2024 outflows, which may stress cash flows and elevate balance sheet leverage.
  • Restructuring Charges and Costs: Periodic restructuring charges, fluctuating between $0.3 million to $3.2 million quarterly, have increased in Q1 and Q2 2024/2025, potentially indicating ongoing operational challenges or integration costs.

Summary: CTS continues to deliver improving revenue and profit trends while generating strong operating cash flow. The company's investments in assets and acquisitions signal long-term growth strategy, but the significant acquisition outlays and restructuring expenses warrant close attention. CTS’s ability to sustain earnings growth, manage working capital efficiently, and optimize its capital structure will be key factors influencing future stock performance.

08/08/25 03:19 AMAI Generated. May Contain Errors.

Frequently Asked Questions About CTS's Financials

When does CTS's financial year end?

According to the most recent income statement we have on file, CTS's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CTS's net income changed over the last 10 years?

CTS's net income appears to be on an upward trend, with a most recent value of $58.11 million in 2024, rising from $26.52 million in 2014. The previous period was $60.53 million in 2023. Find out what analysts predict for CTS in the coming months.

What is CTS's operating income?
CTS's total operating income in 2024 was $72.78 million, based on the following breakdown:
  • Total Gross Profit: $189.15 million
  • Total Operating Expenses: $116.37 million
How has CTS's revenue changed over the last 10 years?

Over the last 10 years, CTS's total revenue changed from $404.02 million in 2014 to $515.77 million in 2024, a change of 27.7%.

How much debt does CTS have?

CTS's total liabilities were at $237.22 million at the end of 2024, a 10.7% increase from 2023, and a 41.9% increase since 2014.

How much cash does CTS have?

In the past 10 years, CTS's cash and equivalents has ranged from $91.77 million in 2020 to $163.88 million in 2023, and is currently $94.33 million as of their latest financial filing in 2024.

How has CTS's book value per share changed over the last 10 years?

Over the last 10 years, CTS's book value per share changed from 8.66 in 2014 to 17.63 in 2024, a change of 103.6%.


Related Companies

This page (NYSE:CTS) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Protect Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsored
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...
Brownstone Research | Sponsored
Critical AI announcement set to ignite AI 2.0
A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...
Timothy Sykes | Sponsored
Trump’s new nightmare
According to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...
Porter & Company | Sponsored